➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: May 24, 2020

DrugPatentWatch Database Preview

Litigation Details for MYLAN LABORATORIES, INC. v. LEAVITT (D.C. 2007)

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in MYLAN LABORATORIES, INC. v. LEAVITT
The small molecule drugs covered by the patent cited in this case are   Start Trial ,   Start Trial , and   Start Trial .


Date Filed Document No. Description Snippet Link To Document
2007-03-23 1 Complaint s U.S. Patent No. 4,572,909 (“the ‘909 patent”) and U.S. Patent No. 4,879,303 (“the ‘303 patent”) because…issued as U.Si Patent No. 4,572,909 (“the ’909 patent”) on February 25, 19862 The ’909 patent claims certain… ’909 patent in view of U.S. Patent 4,032,637 to Spiegel (1977) (“Spiegel") and U.S. Patent 3,816,612… ’303 patent were anticipated by the disclosure of the ’909 patent, (2) whether the 1303 patent was invalid… or not infringed The ‘909 patent has already expired, and the ‘303 patent will expire on March 25, 2007 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.